Segment reporting (Tables)

3 Months Ended

Nov. 30, 2022

Segment Reporting [Abstract]

Reconciliation of Operating Income (Loss) from Segments to Consolidated

The following table reflects results of operations of the Company’s reportable segments (in millions):

	Three months ended November 30,
	2022		2021
Sales:
U.S. Retail Pharmacy	$	27,204	$	28,032
International	5,189		5,818
U.S. Healthcare	989		51
Walgreens Boots Alliance, Inc.	$	33,382	$	33,901
Adjusted operating income (Non-GAAP measure):
U.S. Retail Pharmacy	$	1,105	$	1,690
International	116		164
U.S. Healthcare	(152)		(13)
Corporate and Other	(56)		(63)
Walgreens Boots Alliance, Inc.	$	1,014	$	1,777

The following table reconciles adjusted operating income to operating income (in millions):

	Three months ended November 30,
	2022		2021
Adjusted operating income (Non-GAAP measure)	$	1,014	$	1,777
Certain legal and regulatory accruals and settlements	(6,554)		—
Acquisition-related amortization	(330)		(165)
Transformational cost management	(138)		(203)
Adjustments to equity earnings in AmerisourceBergen	(86)		(43)
Acquisition-related costs	(39)		(71)
LIFO provision	(18)		(14)
Operating (loss) income (GAAP measure)	$	(6,151)	$	1,283